Intranasal octenidine for methicillin-resistant Staphylococcus aureus (MRSA) carriers and universal octenidine bathing reduced MRSA acquisition in an acute-care general ward

Link to article at PubMed

Infect Control Hosp Epidemiol. 2021 Jul 16:1-4. doi: 10.1017/ice.2021.300. Online ahead of print.


In this quasi-experimental before-and-after study in a methicillin-resistant staphylococcus aureus (MRSA) high-prevalence acute-care dermatology ward from August 2016 to November 2018, patients admitted during intervention period who received additional topical intranasal octenidine were 63% less likely to acquire MRSA than those receiving universal daily octenidine bathing alone during baseline period (aOR, 0.37; 95% CI, 0.14-0.98).

PMID:34266515 | DOI:10.1017/ice.2021.300

Leave a Reply

Your email address will not be published.